Craigmatthew
Well-known member
ETA on this bad boy?
LMAO thats too funny :toofunny: <--- see too funny smiley agrees.I'M SOOOOOOO ANXIOUS TOO, I WANT IT NOW !!!!!
Invalid Link Removed
LMAO thats too funny :toofunny: <--- see too funny smiley agrees.
So sick, I started laughing when it hit the chorus and the dino closes his(her) eyes and starts rockin out, lol.
I hope its up on NP tomorrow...
How long is this stable/usable in an unopened container?
Ordered 3 but may pick up more
How long is this stable/usable in an unopened container?
Ordered 3 but may pick up more
2 years
I think I'm going to hop in on an order, got a few other things to pick up as well.Grabbed 2![]()
picked up 3!! Yes months on P-slin!!
Why is it dosed at 400 mg's when caps come in 500 mg's??
Z
I asked the same question a minute ago in a different thread ..
PSlin caps = 500mg/cap.
USpowder PSlin Bulk = 21 grams ( .5 grams) = 42 servings @ 500mg/serving ..
Right ?
Will there be a write-up coming for this "monster shake" mentioned on the Nutraplanet page?
bump...what's the moster shake? :burg:
bumphow does this stuff come is it in a sealed tub, cause i dont want to have any issues with autralian customs
MrZ; said:Next question? How can you possibly make 80 doses at 400 mg's from 21 g???? More like 52,5?
You are right with the arithmetic. Consider 80 doses something like the maximum number of doses from the tub!![]()
I think I'm going to hop in on an order, got a few other things to pick up as well.
MrZ; said:I guess the number of doses could be endless if you take really small doses....
MrZ; said:What I want is 80 effective doses and the question is if 262,5 mgs is an effective dose?? If not I dont understand ...
Thats half he capped dose and Im nor sure the higher amount of LS will make that enough...
It's all about making muscle very fast:burg::box:
coming to the NP forum near you MONDAY!
guys, 265 should be more then enough to get a great effect, specially when dosed 2x's a day and the compound effect builds up.
When we beta tested the Pslin was in much smaller doses and we took 2 caps to start and then ventured to higher doses.... the difference between 2 and 3 caps was very little and dosing higher then 3 caps at once brought no more effect IMO and was more dependent on what you ATE with it then anything.
The final production dose was said to be between the 2 and 3 cap mark from the beta version so I can say without a doubt that 265 compared to 300 is still going to be VERY effective... remember its more dependent on WHAT you eat with it and the timing used. should be GREAT dosing this 2x ed.... still waiting on some expendable finances though![]()
To be correct, this is actually a better deal because I upped the super active extract of Lagerstroemia speciosa [LS] and excluded the gymnena.
....
Regular P-SLIN has 300mgs of LS and with bulk, you are receiving 400mgs!
The capped version of P-Slin has about 30mg of pure corosolic acid.
Next question? How can you possibly make 80 doses at 400 mg's from 21 g???? More like 52,5?
It was posted with the writeup at Invalid Link Removed . I'm not sure where we got that from, I just post up the good news :type:I'm not sure who said it was 80 doses....I just said you can double dose P-SLIN for 1 month with the reccomended protocol of 1 day off a week.
With that said 1 box of PSLIN has 9 grams of our LS extract...
Trying to do the math for the consumers out loud here; the 300mg of LS in regular PSlin converts into 30mg of pure corosolic acid (CA), therefore the LS is 10% CA. A 400mg dose should provide 40mg of CA, and from 21g we would expect 2.1g of pure CA correct?
Also confirming the LS is extracted for the CA, and not for any other extracts correct?
SokVichet; said:StrategicMove, in your expert opinion, what would the optimal dose be when taking twice daily (carb dosing as well)? What about days where I only get a chance to dose once? I'm looking for a focus on effectiveness rather than cost control in this question. I realize, poopy, that you are saying 265mg per dose would be 'adequate', but I'm digging for the most optimal dosingAnd thank you for your input as well.
Before I realized the formula is different than the caps, I was planning to just follow the bottle protocol, but it appears I need your expert help here.
Thanks in advance!
Biol Pharm Bull. 2008 Apr;31(4):651-5.
Dietary corosolic acid ameliorates obesity and hepatic steatosis in KK-Ay mice.
Yamada K, Hosokawa M, Yamada C, Watanabe R, Fujimoto S, Fujiwara H, Kunitomo M, Miura T, Kaneko T, Tsuda K, Seino Y, Inagaki N.
Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-ku, Kyoto , Japan.
Corosolic acid (CRA), a constituent of Banaba leaves, has been reported to exert anti-hypertension, anti-hyperinsulinemia, anti-hyperglycemia, and anti-hyperlipidemia effects as well as to induce anti-inflammatory and anti-oxidative activities. The aim of this study was to investigate the inhibitory effects of CRA on the development of obesity and hepatic steatosis in KK-Ay mice, a genetically obese mouse model. Six-week-old KK-Ay mice were fed a high fat diet for 9 weeks with or without 0.023% CRA. Nine-week CRA treatment resulted in 10% lower body weight and 15% lower total fat (visceral plus subcutaneous fat) mass than in control mice. CRA treatment reduced fasting plasma levels of glucose, insulin, and triglyceride by 23%, 41%, and 22%, respectively. The improved insulin sensitivity in CRA-treated mice may be due on part to the increased plasma adiponectin and white adipose tissue (WAT) AdipoR1 levels. In addition, CRA treatment increased the expression of peroxisome proliferator-activated receptor (PPAR) alpha in liver and PPAR gamma in WAT. This is the first study to show that CRA treatment can contribute to reduced body weight and amelioration of hepatic steatosis in mice fed a high fat diet, due in part to increased expression of PPAR alpha in liver and PPAR gamma in WAT.
PMID: [PubMed - indexed for MEDLINE]
Life Sci. 2006 Nov 25;79(26):2474-9. Epub 2006 Aug 17.
Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome.
Yamaguchi Y, Yamada K, Yoshikawa N, Nakamura K, Haginaka J, Kunitomo M.
Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, 11-68, Koshien Kyuban-cho, Nishinomiya , Japan. [email protected]
Corosolic acid (CRA), a constituent of banaba leaves, has been reported to have anti-inflammatory and hypoglycemic activities. The aim of this study was to determine the effects of CRA on metabolic risk factors including obesity, hypertension, hyperinsulinemia, hyperglycemia, and hyperlipidemia together with oxidative stress and inflammation, all of which are characteristic of the SHR/NDmcr-cp (cp/cp) (SHR-cp) rat, an animal model of metabolic syndrome. Six-week-old male SHR-cp rats were fed a high fat diet containing 0.072% CRA for 14 weeks. Treatment with CRA lowered blood pressure, which was elevated in control animals, by 10% after 8 weeks, and serum free fatty acids by 21% after 2 weeks. CRA treatment resulted in decreases in the levels of the oxidative stress markers thiobarbituric acid-reactive substances and 8-hydroxydeoxyguanosine by 27% and 59%, respectively, after 2 weeks. CRA treatment also reduced the levels of myeloperoxidase markers, 3-nitrotyrosine and 3-chlorotyrosine by 38% and 39%, respectively, after 10 weeks, and tended to decrease the levels of high sensitivity C-reactive protein, a marker of inflammation, after 6 weeks. However, CRA had no effect on weight gain or hyperglycemia. These results demonstrate that CRA can ameliorate hypertension, abnormal lipid metabolism, and oxidative stress as well as the inflammatory state in SHR-cp rats. This implies that CRA can be beneficial for preventing atherosclerosis-related diseases that are an increasing health care problem worldwide.
PMID: [PubMed - indexed for MEDLINE]
Diabetes Res Clin Pract. 2006 Aug;73(2):174-7. Epub 2006 Mar 23.
Effect of corosolic acid on postchallenge plasma glucose levels.
Fukushima M, Matsuyama F, Ueda N, Egawa K, Takemoto J, Kajimoto Y, Yonaha N, Miura T, Kaneko T, Nishi Y, Mitsui R, Fujita Y, Yamada Y, Seino Y.
Department of Diabetes and Clinical Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan. [email protected]
Corosolic acid (CRA) is a substance extracted from Lagerstroemia speciosa L. and has been reported to have biological activities in in vitro and experimental animal studies. In this study, 31 subjects were orally administered 10mg CRA or a placebo, on different occasions, in a capsule 5min before the 75-g oral glucose tolerance test (OGTT) in a double-blind and cross-over design. Nineteen subjects had diabetes, seven had impaired glucose tolerance, one had impaired fasting glucose, and four had normal glucose tolerance according to the 1998 WHO criteria. There were no significant differences in plasma glucose levels before and 30min after the administration. CRA treatment subjects showed lower glucose levels from 60min until 120min and reached statistical significance at 90min. In this study, we have shown for the first time that CRA has a lowering effect on postchallenge plasma glucose levels in vivo in humans.
PMID: [PubMed - indexed for MEDLINE]
well its a "new" avi actually.... but its a cut out I just did of an old pic right when I started working out... lol.is that an old avy of you poop?